The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.
Sexual health is about so much more than infection prevention – it’s about being happy with yourself and in your sex life. Help us to spread the word that everyone has a right to pleasurable and safer sex!
Women who sell sex are experiencing high levels of mental health issues, reveals a groundbreaking evidence review.
The first evidence review to focus on men who buy sex – rather than women who sell it – finds a strong association between purchasing sex and HIV.
Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.
We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.
The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.
Peer distribution, youth branding and social media campaigns emerge as top ideas in crowdsourcing contest to improve HIV self-testing among young people.
World Health Organization changes its position on the wearing of non-medical fabric face masks.
Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.